STANDARD BIOTOOLS INC. - COMMON STOCK

Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series

30 May 2025 04:00:00 By Nasdaq GlobeNewswire

Standard BioTools Reports First Quarter 2025 Financial Results

06 May 2025 13:01:00 By Nasdaq GlobeNewswire

Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025

24 Apr 2025 04:00:00 By Nasdaq GlobeNewswire

Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025

22 Apr 2025 04:00:00 By Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

27 Feb 2025 13:01:00 By Nasdaq GlobeNewswire

Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results

26 Feb 2025 13:01:00 By Nasdaq GlobeNewswire

Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025

12 Feb 2025 04:00:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

13 Jan 2025 04:00:00 By Nasdaq GlobeNewswire

Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine

08 Jan 2025 04:00:00 By Nasdaq GlobeNewswire

Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference

19 Dec 2024 05:00:00 By Nasdaq GlobeNewswire

Standard BioTools Appoints Alex Kim as Chief Financial Officer

07 Nov 2024 05:00:00 By Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

31 Oct 2024 05:01:00 By Nasdaq GlobeNewswire

Standard BioTools Reports Third Quarter 2024 Financial Results

30 Oct 2024 13:01:01 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

16 Oct 2024 05:00:00 By Nasdaq GlobeNewswire

Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform

24 Sep 2024 05:00:00 By Nasdaq GlobeNewswire

Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)

18 Sep 2024 05:00:00 By Nasdaq GlobeNewswire

Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

26 Aug 2024 05:00:00 By Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

06 Aug 2024 13:01:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Senior Leadership Changes

31 Jul 2024 13:02:00 By Nasdaq GlobeNewswire

Standard BioTools Reports Second Quarter 2024 Financial Results

31 Jul 2024 13:01:00 By Nasdaq GlobeNewswire